Last10K.com

Nascent Biotech Inc. (NBIO) SEC Filing 10-Q Quarterly Report for the period ending Saturday, September 30, 2023

SEC Filings

NBIO Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

NBIO Annual Reports

NBIO Quarterly Reports

NBIO Corporate News

NBIO Registration of Securities

Nascent Biotech Inc.

HISTORY TOOLS
CIK: 1622057 Ticker: NBIO
Cover - shares
6 Months Ended
Sep. 30, 2023
Nov. 09, 2023
Cover [Abstract]  
Entity Registrant NameNASCENT BIOTECH INC 
Entity Central Index Key0001622057 
Document Type10-Q 
Amendment Flagfalse 
Current Fiscal Year End Date--03-31 
Entity Small Businesstrue 
Entity Shell Companyfalse 
Entity Emerging Growth Companyfalse 
Entity Current Reporting StatusYes 
Document Period End DateSep. 30, 2023 
Entity Filer CategoryNon-accelerated Filer 
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2024 
Entity Common Stock Shares Outstanding 166,735,430
Entity File Number000-55299 
Entity Incorporation State Country CodeNV 
Entity Tax Identification Number46-5001940 
Entity Address Address Line 1631 Hwy 1 Suite 407 
Entity Address City Or TownNorth Palm Beach 
Entity Address State Or ProvinceFL 
Entity Address Postal Zip Code33408 
City Area Code612 
Local Phone Number961-5656 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate Nascent Biotech Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nascent Biotech Inc..

Continue

Assess how Nascent Biotech Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nascent Biotech Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Nascent Biotech Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Certification
Exhibit 31.2: Certification
Exhibit 32.1: Certification
Exhibit 32.2: Certification
Ticker: NBIO
CIK: 1622057
Form Type: 10-Q Quarterly Report
Accession Number: 0001477932-23-008227
Submitted to the SEC: Thu Nov 09 2023 2:47:37 PM EST
Accepted by the SEC: Thu Nov 09 2023
Period: Saturday, September 30, 2023
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/nbio/0001477932-23-008227.htm